RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$56.77
-0.49 (-0.86%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+28.88%
1Y
+51.06%
YTD
+46.09%
Open$57.44
Previous Close$57.26
Day High$57.66
Day Low$56.60
52W High$60.44
52W Low$34.08
Volume—
Avg Volume2.68M
Market Cap32.65B
P/E Ratio40.06
EPS$1.46
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.77
Above
SMA 200
$37.28
Above
RSI (14)
85.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-36.1% upside
Current
$56.77
$56.77
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.42B | 2.37B | 6.69B |
| Net Income | 785.41M | 692.60M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.59B | 1.48B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield1.64%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |